Wiseguyreports.Com Adds “Plasma Therapy -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database
The market for plasma therapy across the globe is expected to propel significantly during the forecast period. According to analysts’ estimate the plasma therapy market is expected to grow impressively with a CAGR of 13.8% during 2016-2021. The factors driving the plasma therapy market are rising prevalence of life threatening diseases which includes various neurological system disorders like chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), multifocal motor neuropathy (MMN). In addition the rise in the occurrence of contagious diseases such as hepatitis A&B, tetanus and rabies is estimated to impact the market positively during the forecast period.
With an impressive technological advancement over the period has added much more to the therapies for treatment of various diseases which has also led to introduction of cost effective protein fractioning technologies from plasma. This is also being seen as a major booster to the growth within the plasma therapy market during the forecast period. As per estimates by WHO about 108 million global blood donations come from the high income countries, which is the home for 18% of the world’s population. Presence of favorable government initiates for the development of plasma derived medicine and rising awareness regarding the importance of blood donation are the key drivers for this market.
On the geographical forefront, North America is a leader held the market share in 2014 which is expected to sustain during the forecast period as well. This is mainly due to the growing number of hospitals and clinics which is increasing the demand for the plasma derived from proteins. They key driving forces expected to boost the market of plasma therapy in North America are rising awareness levels among the blood donors, presence of advanced protein fractioning procedures, and higher per capita income in the developed countries.
Furthermore, APAC region is also considered to be fastest growing region mainly due to growing medical tourism, technological advancement, rising disposable income of the patients, rising healthcare practitioners awareness, and increasing government initiatives pertaining to the development of plasma protein medicines are expected to fuel the demand of plasma protein products.
The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, gap analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Key players of plasma therapy market include CSL limited, Telecris, Baxter, Grifols, Octapharma, Kedrion, and Chengdu Inst. Many not-for-profit organizations such as Japan Red Cross, LFB group (France), Shanghai Blood Institute, BPL group (UK), and Sanquin are also playing a vital role in plasma therapy market. The growth of commercial companies may be hampered by the not-for-profit organizations but the current demand supply gap in the market provides great scope for the new entrants during the forecast period.
• Comprehensive research methodology of global plasma therapy market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global plasma therapy market
• Insights about market determinants which are stimulating the global plasma therapy market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players
Table of Content
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
188.8.131.52. RAW MATERIAL SUPPLIERS
2. MARKET OVERVIEW AND INSIGHTS
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.5. REST OF THE WORLD
2.4. PATENT ANALYSIS
4. MARKET SEGMENTATION
4.1. PLASMA THERAPY BY SOURCE
4.2. PLASMA THERAPY BY APPLICATION
184.108.40.206. BONE REPAIR AND REGENERATION
220.127.116.11. CHRONIC TENDINITIS
4.2.2. CARDIAC MUSCLE INJURY
18.104.22.168. ANDROGENIC ALOPECIA
22.214.171.124. PLASTIC SURGERY
4.2.5. NERVE INJURY
4.2.6. OTHER APPLICATIONS
4.3. PLASMA THERAPY BY TYPE
4.3.1. LEUKOCYTE-RICH FIBRIN
4.3.2. PURE PLATELET-RICH FIBRIN
4.3.3. LEUKOCYTE-RICH PRP
4.3.4. PURE PRP
4.4. PLASMA THERAPY BY END USERS
4.4.1. HOSPITALS AND CLINICS
4.4.2. RESEARCH INSTITUTES
5. PRICING ANALYSIS
5.1. PRICING ANALYSIS (BY SIZE, EQUIPMENT AND SUPLLIES)
6. COMPETITIVE LANDSCAPE
6.1. KEY COMPANY ANALYSIS
6.2. KEY STRATEGIES
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Phone: +1 646 845 9349, +44 208 133 9349